HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.

Abstract
The blood-brain barrier (BBB) disruption is a critical step in paraneoplastic neurological syndrome (PNS) development. Several cytokines have been implicated in BBB breakdown. However, the exact step-by-step mechanism in which PNS develops is unknown, and the relationship between a systemic neoplasm and BBB is multilevel. The aim of the present study was to examine serum markers of BBB breakdown (S100B protein, neuron-specific enolase, NSE) and concentrations of proinflammatory (TNF-alpha, VEGF) and anti-inflammatory/immunosuppressive cytokines (IL-4), and to establish their interrelationship in patients with PNS. We analyzed 84 patients seropositive for onconeural antibodies that originated from a cohort of 250 cases with suspected PNS. Onconeural antibodies were estimated with indirect immunofluorescence and confirmed with Western blotting. Serum S-100B was estimated using electrochemiluminescence immunoassay. NSE, VEGF, TNF-alpha and IL-4 were analyzed with ELISA. We found that S-100B protein and NSE serum concentrations were elevated in PNS patients without diagnosed malignancy, and S-100B additionally in patients with peripheral nervous system manifestation of PNS. Serum VEGF levels showed several abnormalities, including a decrease in anti-Hu positive patients and increase in PNS patients with typical manifestation and/or central nervous system involvement. Increase in TNF-alpha was observed in patients with undetermined antibodies. To conclude, the presence of paraneoplastic neurological syndrome in seropositive patients does not affect serum markers of BBB breakdown, with the exception of the group without clinically demonstrated malignancy and patients with peripheral manifestation of PNS. S-100B and NSE might increase during early phase of PNS. VEGF may be involved in typical PNS pathophysiology.
AuthorsSlawomir Michalak, Alicja Kalinowska-Lyszczarz, Joanna Rybacka-Mossakowska, Mikolaj Zaborowski, Wojciech Kozubski
JournalJournal of neural transmission (Vienna, Austria : 1996) (J Neural Transm (Vienna)) Vol. 126 Issue 2 Pg. 149-158 (Feb 2019) ISSN: 1435-1463 [Electronic] Austria
PMID30374596 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Biomarkers, Tumor
  • IL4 protein, human
  • S100 Calcium Binding Protein beta Subunit
  • S100B protein, human
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Interleukin-4
  • Phosphopyruvate Hydratase
Topics
  • Adult
  • Biomarkers (blood)
  • Biomarkers, Tumor (blood, immunology)
  • Blood-Brain Barrier (immunology, pathology)
  • Cohort Studies
  • Female
  • Humans
  • Interleukin-4 (blood)
  • Male
  • Middle Aged
  • Paraneoplastic Syndromes, Nervous System (blood, immunology)
  • Phosphopyruvate Hydratase (blood)
  • S100 Calcium Binding Protein beta Subunit (blood)
  • Tumor Necrosis Factor-alpha (blood)
  • Vascular Endothelial Growth Factor A (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: